AI Article Synopsis

  • Jayne et al. reveal the molecular details of a specific chromosomal translocation (t(1;6)(p35.3;p25.2)) found in chronic lymphocytic leukaemia patients.
  • This translocation involves the IRF4 gene on chromosome 6 and the RCC1 gene on chromosome 1, indicating a fusion between RCC1 and IRF4.
  • The study suggests that this chromosomal abnormality could have significant prognostic implications for patients with this type of leukaemia.

Article Abstract

Jayne et al. provide a molecular characterization of the t(1;6)(p35.3;p25.2) chromosomal translocation in patients with chronic lymphocytic leukaemia. They indicate that this translocation involves the gene encoding interferon regulatory factor 4 (IRF4) on chromosome 6p25.2 with the regulator of chromosome condensation 1 (RCC1) gene on chromosome 1p35.3. This translocations may have important prognostic value. Commentary on: Jayne et al. The chromosomal translocation t(1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia leads to RCC1::IRF4 fusion. Br J Haematol 2024; 205:2321-2326.

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.19821DOI Listing

Publication Analysis

Top Keywords

chromosomal translocation
12
rcc1irf4 fusion
8
t16p353p252 chromosomal
8
jayne et al
8
chronic lymphocytic
8
lymphocytic leukaemia
8
discovery rcc1irf4
4
fusion cll
4
cll patients
4
patients t16p353p252
4

Similar Publications

Background: AML-M4Eo is a type of AML characterized by malignant proliferation of granulocyte and monocyte precursor cells accompanied by eosinophilia. Patients present as anemia, infection, bleeding, and tissue and organ infiltration. MICM classification makes the classification of AML more accurate and lays a foundation for the correct treatment and prognosis of AML.

View Article and Find Full Text PDF

Predictive modelling of acute Promyelocytic leukaemia resistance to retinoic acid therapy.

Brief Bioinform

November 2024

Department of Biology, École Normale Supérieure, 46 rue d'Ulm, 75005 Paris, France.

Acute Promyelocytic Leukaemia (APL) arises from an aberrant chromosomal translocation involving the Retinoic Acid Receptor Alpha (RARA) gene, predominantly with the Promyelocytic Leukaemia (PML) or Promyelocytic Leukaemia Zinc Finger (PLZF) genes. The resulting oncoproteins block the haematopoietic differentiation program promoting aberrant proliferative promyelocytes. Retinoic Acid (RA) therapy is successful in most of the PML::RARA patients, while PLZF::RARA patients frequently become resistant and relapse.

View Article and Find Full Text PDF

The importance of conserving plant genetic diversity has been recognised since the 1980's, but genetic research tools for improving conservation remain largely absent from standard planning. Using an Australian case study framework of the New South Wales Government's Saving our Species program, we outline the costs and benefits associated with conducting genomic analysis within a conservation strategy to inform for example, taxonomic resolution, targeted monitoring, translocations and ex situ collections. Despite a reported sentiment that costs are prohibitive, our study identified that where genetics reports have been provided (32 to date), the cost of genetic sampling, analysis and advice is less than 10% of the total Government investment (SoS program) and will continue decreasing proportionally throughout the years as other management occurs.

View Article and Find Full Text PDF

Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis.

Mol Neurodegener

January 2025

College of Life Sciences and Oceanography, Brain Disease and Big Data Research Institute, Shenzhen University, Shenzhen, 518060, Guangdong, China.

Background: Astrocytes, the most abundant glial cell type in the brain, will convert into the reactive state in response to proteotoxic stress such as tau accumulation, a characteristic feature of Alzheimer's disease (AD) and other tauopathies. The formation of reactive astrocytes is partially attributed to the disruption of autophagy lysosomal signaling, and inhibiting of some histone deacetylases (HDACs) has been demonstrated to reduce the molecular and functional characteristics of reactive astrocytes. However, the precise role of autophagy lysosomal signaling in astrocytes that regulates tau pathology remains unclear.

View Article and Find Full Text PDF

Chronic myeloid leukemia (CML) is a myeloproliferative disorder that commonly manifests in chronic, accelerated, or blast phase. Typically observed in individuals aged 60-65 years, CML is infrequently diagnosed in adolescents. The usual presentation in late adulthood involves nonspecific symptoms such as fever, fatigue, and weight loss, with rare reports of initial neurological involvement.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!